Navigation Links
Childhood asthma still inappropriately treated in the UK
Date:9/3/2007

Children with asthma are missing out on the best drug treatment for their disease, because family doctors are ignoring prescribing guidelines, suggests research published ahead of print in the Archives of Disease in Childhood.

Around a million children in the UK have asthma, and the disease prompts up to a third of children aged between 5 and 13 to visit their doctor.

The researchers used national data to calculate the number of prescriptions issued for asthma drugs by doctors working in the community in the UK between 2000 and 2006.

These figures were then matched with guidance issued by the British Thoracic Society (BTS), updated in 2005, on the most appropriate drug treatments for children with asthma.

The guidance discourages the use of syrups designed to open up the airways (bronchodilator syrups), because they have a systemic rather than a targeted effect, and dont actually control asthma symptoms very well.

But the figures showed that although prescriptions for this type of medication fell by 60%, 121,000 prescriptions for the medicine were still written in 2006.

Despite concerns about the effects of long acting beta agonists (LABAs) in children, and recommendations to curb their use, the total number of these prescriptions almost doubled.

And the percentage of prescriptions for combination inhalers, containing steroid and a LABA, rose 7-fold from 2.6% to 20.5%.

The BTS guidance recommends that combination inhalers should be used only when appropriate dose steroid inhalers fail to control the asthma adequately (persistent asthma).

Persistent asthma accounts for only 5 to 10% of childhood asthma, say the authors.

The authors note that the changes in prescribing practice are unlikely to be the result of an increase in the prevalence of asthma.

Nor are they likely to be attributable to population changes, because children under the age of 18 in the UK fell between 2000 and 2006, they say.


'/>"/>
Contact: Emma Dickinson
edickinson@bmj.com
44-020-738-36529
BMJ Specialty Journals
Source:Eurekalert

Related medicine news :

1. Preventing Childhood Deaths
2. Umbilical Cord Blood Could Predict Childhood Allergies
3. Focused Treatment For Childhood Cancer
4. Osteoporosis associated with Childhood Cancer
5. Stroke also in list of common childhood ailments
6. Asthma is not just a childhood condition
7. Asthma not just a childhood condition
8. Childhood Sunburn Can Lead to Skin Cancer Later
9. Radiation Not Needed for Childhood Cancers
10. Troubled Childhood found to affect your Liver
11. Elevated LDL levels in Childhood could be Predictors of Heart Disease
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/8/2016)... ... December 08, 2016 , ... The West Virginia Medical Institute ... The name change aligns the entire company with its existing Quality Insights ... , “We are very proud of the achievements associated with the West Virginia ...
(Date:12/8/2016)... (PRWEB) , ... December 08, 2016 , ... ... Donuts Franchising Company LLC, announced the first national #QuackGivesBack campaign which supported ... , “This was our first franchise-wide Quack Gives Back initiative, and ...
(Date:12/8/2016)... ... 08, 2016 , ... Mirixa Corporation , a leading ... pharmacist-delivered patient care services, has announced the promotions of Karen Litsinger to senior ... of sales. , Litsinger joined Mirixa in 2008 after serving as a ...
(Date:12/8/2016)... (PRWEB) , ... December 08, 2016 , ... David ... with global law firm Greenberg Traurig, LLP, will speak at DeviceTalks West, Dec. 12, ... of the DeviceTalks series, and attorneys from the firm’s global Life Sciences & Medical ...
(Date:12/8/2016)... ... December 08, 2016 , ... ... development continuity to its innovative Unified Instance Manager architecture, meeting the needs ... this new version optimizes the unattended auto-dialing system without agents, Presence Robodialer, ...
Breaking Medicine News(10 mins):
(Date:12/9/2016)... , Dec. 9, 2016 aTyr Pharma, Inc. (Nasdaq: ... development of Physiocrine-based therapeutics to address severe, rare diseases, today announced ... upcoming BMO Prescriptions for Success Healthcare Conference at the InterContinental Barclay ... December 14, 2016, at 4:20 p.m. ET. About ... ...
(Date:12/9/2016)... , Dec. 9, 2016 Department of Health ... regulations for medical marijuana dispensaries under Act 16 are ... , and are now available online . ... in the plan for operation; process for dispensing medical ... well as where the dispensary facilities can be located," ...
(Date:12/8/2016)... VIEW, Calif. , Dec. 8, 2016 IRIDEX ... intends to offer newly issued shares of common stock, $0.01 ... pursuant to an underwritten public offering.  The final terms of ... the time of pricing, and there can be no assurance ... IRIDEX expects to use the net proceeds it ...
Breaking Medicine Technology: